|
Contents |
|
|
|
|
|
|
|
Choroid
Plexus Tumors
|

|
|
|
Timothy
J, Chumas P, Chakrabarty A, Drake JM, Morrison E
Destruction of choroid plexus cells in vitro: a new concept
for the treatment of hydrocephalus
Neurosurgery. 2004 Mar;54(3):727-32
|
|
|
Medulloblastoma
|

|
|
|
Peter
A Forsyth, Wen Qing Yang, Donna Senger, Huong Muzik, Zhong Q Shi, Penny
Brasher, Richard Dyck
Reovirus
oncolysis in medulloblastoma is effective in vivo and safe in rodents and
primates
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
Abstract No.
289
|
|
|
Neuroblastoma |

|
|
|
A. Batova, A. L. Yu, D. Strother,
P. Angelini, A. Eskenazi
Promising results of a pilot trial of a GD2
directed anti-idiotypic antibody as a vaccine for high risk neuroblastoma
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8511
|
|
|
Joshi AD, Clark EM, Wang P, Munger CM, Hegde GV,
Sanderson S, Dave HP, Joshi SS
Immunotherapy of human neuroblastoma using umbilical cord blood-derived
effector cells
J
Neuroimmune Pharmacol. 2007 Jun;2(2):202-12.
Epub 2006 Oct 11
Abstract
|
|
|
Tahira Khan,
Julie A.
Hixon, Jimmy K. Stauffer, Erin Lincoln, Timothy
C. Back, Jason Brenner, Stephen Lockett, Kunio
Nagashima, Douglas Powell, Jon M. Wigginton
Therapeutic Modulation of Akt Activity and
Antitumor Efficacy of Interleukin-12 Against Orthotopic Murine Neuroblastoma
Journal of the National Cancer Institute, Vol. 98, No. 3, 190-202, February 1,
2006
Abstract
|
News
|
|
|
Mario Otto,
Raymond C. Barfield, William
J. Martin, Rekha Iyengar,
Wing Leung, Thasia
Leimig, Stanley Chaleff,
Stephen D. Gillies and Rupert
Handgretinger
Combination Immunotherapy with Clinical-Scale
Enriched Human γδ T cells, hu14.18 Antibody, and the Immunocytokine
Fc-IL7 in Disseminated Neuroblastoma
Clinical Cancer Research Vol. 11, 8486-8491, December 1, 2005
Abstract
|
News
|
|
|
Non-CNS
Tumors
|

|
|
| |
Batliwalla
FM, Bateman BA, Serrano D, Murray D, Macphail S, Maino VC, Ansel JC,
Gregersen PK, Armstrong CA
A 15-year
follow-up of AJCC stage III malignant melanoma patients treated postsurgically
with Newcastle disease virus (NDV) oncolysate and determination of alterations
in the CD8 T cell repertoire
Mol
Med 1998 Dec;4(12):783-94
|
|
Csatary
LK, Eckhardt S, Bukosza I, Czegledi F, Fenyvesi C, Gergely P, Bodey B,
Csatary CM
Attenuated
veterinary virus vaccine for the treatment of cancer
Cancer
Detect Prev 1993;17(6):619-27
|
|
Grant
SC, Kris MG, Houghton AN, Chapman PB
Long
survival of patients with small cell lung cancer after adjuvant treatment with
the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guerin
Clin Cancer Res 1999 Jun;5(6):1319-23
|
|
Pecora AL, Rizvi N, Cohen GI, Meropol NJ, Sterman D, Marshall JL,
Goldberg S, Gross P, O'Neil JD, Groene WS, Roberts MS, Rabin H, Bamat MK,
Lorence RM
Phase I
trial of intravenous administration of PV701, an oncolytic virus, in patients
with advanced solid cancers
J
Clin Oncol 2002 May 1;20(9):2251-66
|

|